These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 13681936)

  • 1. [Studies on antistreptolysin O in childhood. 2. Antistreptolysin O value in respiratory tract diseases, scarlet fever, and kidney diseases].
    AKIYAMA N
    Paediatr Jpn; 1961 Jul; 65():729-36. PubMed ID: 13681936
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of the behavior of antistreptolysin titer after recovery from scarlet fever].
    KUPATZ H; KOHLER W
    Monatsschr Kinderheilkd (1902); 1958 Sep; 106(9):393-6. PubMed ID: 13613213
    [No Abstract]   [Full Text] [Related]  

  • 3. [Behavior of antistreptolysin in scarlatinal infections treated with streptococcal vaccine].
    RECCHIA F; RAVAZZONI L
    Boll Ist Sieroter Milan; 1956; 35(5-6):243-54. PubMed ID: 13342188
    [No Abstract]   [Full Text] [Related]  

  • 4. Azidocillin--a new penicillin derivative. 1. Clinical investigation in treatment of scarlet fever.
    Bengtsson E; Holmgren EB; Tunevall G
    Scand J Infect Dis; 1969; 1(2):71-5. PubMed ID: 4999682
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological significance of antistreptolysin O (ASL) in streptococcal infections. III. The antibody response in scarlet fever patients.
    KUSAMA H
    Jpn J Med Sci Biol; 1962 Aug; 15():199-209. PubMed ID: 13927584
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunological significance of antistreptolysin O (ASL) in streptococcal infections. IV. The antibody decline in scarlet fever convalescents.
    KUSAMA H
    Jpn J Med Sci Biol; 1962 Aug; 15():211-9. PubMed ID: 13927585
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes of the antistreptolysin O titer in patients with scarlet fever treated with penicillin].
    PERISIC Z; RADOJEVIC S; BOZOVIC M
    Srp Arh Celok Lek; 1961 Sep; 89():945-51. PubMed ID: 14485356
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antistreptolysin titer and immunity to diseases in scarlet fever].
    WIESENER H; STUCK B
    Klin Wochenschr; 1955 Sep; 33(35-36):845-8. PubMed ID: 13264553
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of antistreptolysin in scarlet fever and some other infectious diseases.
    LAGERCRANTZ R
    Scand J Clin Lab Invest; 1950; 2(2):152-61. PubMed ID: 15424638
    [No Abstract]   [Full Text] [Related]  

  • 10. [Our experiences with antistreptolysin O-reaction in scarlet fever patients].
    Levi-Jovović E; Soldatović K; Stojsić M; Marković R; Stojanović-Mihajlović V
    Hig Cas Hig Mikrobiol Epidemiol Sanit Teh; 1965; 17(1):50-6. PubMed ID: 5296923
    [No Abstract]   [Full Text] [Related]  

  • 11. [Problems of immunologic characteristics in scarlet fever; dynamics of antistreptolysin and antifibrinolysin titers].
    KUZNETSOVA NM
    Vopr Pediatrii; 1953; 21(3):28-9. PubMed ID: 24542745
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of types of treatment on development of antistreptolysin in patients with scarlet fever.
    WEINSTEIN L; TSAO CC
    Proc Soc Exp Biol Med; 1946 Nov; 63(2):449. PubMed ID: 20277780
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the antistreptolysin O titer in hepatitis in childhood].
    EICHLSEDER W
    Z Kinderheilkd; 1960; 84():489-95. PubMed ID: 13726078
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evolution of the antistreptolysin O titer in scarlet fever during prolonged penicillin therapy as compared with the clinical evolution].
    Buşilă VT; Sarlău A; Pintea L
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):347-59. PubMed ID: 5400035
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinico-anamnestic data and laboratory findings in scarlet fever with special reference to the C-reactive protein in the serum and to the AST].
    Dittmer J; Kirchhoff B
    Z Arztl Fortbild (Jena); 1971 Mar; 65(6):310-3. PubMed ID: 5559923
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the diagnostic significance of serum anti-streptococcal diphosphopyridine nucleotidase in streptococcal infections. 2. Its values in various pediatric diseases].
    Murakami T
    Nihon Shonika Gakkai Zasshi; 1967 Apr; 71(4):482-93. PubMed ID: 4294103
    [No Abstract]   [Full Text] [Related]  

  • 17. [NON-SPECIFIC ANTISTREPTOLYSINS IN CASES OF SCARLET FEVER IN CHILDREN].
    FRANCZAK T
    Pediatr Pol; 1964 Jun; 39():671-6. PubMed ID: 14193333
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antistreptolysin "O" dynamics in streptococcal infections treated with penicillin].
    Bărbulescu E
    Rev Med Chir Soc Med Nat Iasi; 1971; 75(1):133-7. PubMed ID: 4994761
    [No Abstract]   [Full Text] [Related]  

  • 19. ASO and latex ASO in upper respiratory tract infection and primary prevention of rheumatic fever [proceedings].
    Watanabe N
    Jpn Circ J; 1977 Feb; 41(2):1750. PubMed ID: 846032
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on antistreptolysin-O in childhood. 3. Antistreptolysin-O value and C-reactive protein in infantile rheumatic fever, and anti-streptolysin value in 2 or 3 seemingly unrelated children's diseases with hemolytic streptococci].
    AKIYAMA N
    Paediatr Jpn; 1961 Aug; 65():781-9. PubMed ID: 13681937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.